Good time to buy. Solid company. Cash flow positive on operations. Good cash balance. Undervalued. Accumulate on weakness as analysts would say (I'm not one).
Quarterly expected end of this month. Hopefully CoVid has not impacted the company. I expect not as the company has not said anything.
- Forums
- ASX - By Stock
- BXN
- BXN outperforming health supplements sector
BXN outperforming health supplements sector, page-4
Featured News
Add BXN (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.51M |
Open | High | Low | Value | Volume |
1.1¢ | 1.2¢ | 1.1¢ | $16.24K | 1.449M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 3796436 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 329821 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 3796436 | 0.010 |
7 | 1505077 | 0.009 |
3 | 475500 | 0.008 |
6 | 3251571 | 0.007 |
5 | 1510066 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 329821 | 1 |
0.012 | 1029918 | 3 |
0.013 | 2347788 | 7 |
0.014 | 1538538 | 3 |
0.015 | 2392833 | 6 |
Last trade - 15.43pm 30/08/2024 (20 minute delay) ? |
Featured News
BXN (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online